FDA NDC Directory · JSON-LD · Markdown

Binosto

NDC 70539-400 · HUMAN PRESCRIPTION DRUG · TABLET, EFFERVESCENT

Generic namealendronate sodium
Labeler / ManufacturerRadius Health, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA202344
Dosage form / routeTABLET, EFFERVESCENT · ORAL
Active ingredientsALENDRONATE SODIUM (91.37 mg/1)
Marketing started20120312
Package count2

External sources

Source: openFDA. Public-domain (CC0).